Deaths in Fablyn clinical trial 04-Sep-2008 According to the US Food and Drug Administration, a higher percentage of patients treated with Pfizer’s osteoporosis drug Fablyn died, compared with those taking a placebo during a clinical trial Read more...

ProStrakan moving towards profit 04-Sep-2008 UK pharma company ProStrakan Group, has predicted that product launches in Europe and the US will take it into profit in 2009 Read more...

Inegy cancer link ‘random chance’ 03-Sep-2008 A small-scale study conducted in Norway has linked Inegy (Vytorin) – Merck/Schering-Plough’s fixed dose formulation of simvastatin and ezetimibe – to an increased risk of developing cancer Read more...

Street use of diazepam soars in UK 03-Sep-2008 A survey of 100 organisations across 20 cities in the UK has revealed a sharp rise in the illegal use of diazepam, particularly among heroin and crack cocaine users Read more...

GSK cardiovascular drug data shows promising results 02-Sep-2008 GlaxoSmithKline has presented data that suggests its investigational cardiovascular drug darapladib, may represent a new approach to predicting a patient’s risk of heart attack or stroke Read more...

HPV vaccination advertised on networking sites 02-Sep-2008 The government has begun a nationwide campaign to raise awareness of its human papilloma virus vaccination programme Read more...

Scotland begins HPV vaccination programme 01-Sep-2008 Authorities in Scotland have begun a national human papilloma virus vaccination programme in girls aged 12 and 13 years old Read more...

UCB cuts 2,000 jobs 01-Sep-2008 Belgian biopharma company UCB is cutting 2,000 jobs, which is around 17 per cent of its workforce, as part of a new global project Read more...